COSMO PHARMACEUTICALS
Updates & Highlights
Number of shareholders of Cosmo Pharmaceuticals NV – FWB:C43
Number of shareholders of Cosmo Pharmaceuticals NV – FWB:C43 - Read more on TradingView
TradingView · about 3 hours ago
Cosmo Pharmaceuticals Reports Positive 12-Month Safety Data for Clascoterone 5% in Male AGA
Cosmo Pharmaceuticals Reports Positive 12-Month Safety Data for Clascoterone 5% in Male AGA - Read more on Dermatolog...
Dermatology Times · 21 days ago
Cosmo Pharma Eyes 2027 NDA for Baldness Candidate After Positive Phase III 12-Month Data
Cosmo Pharma Eyes 2027 NDA for Baldness Candidate After Positive Phase III 12-Month Data - Read more on Genetic Engin...
Genetic Engineering and Biotechnology News · 16 days ago
Recent Openings
View all 1 jobsCulture & Mission
Benefits & Perks
Equity/Stock Options
Ownership in the company
Health Insurance
Medical, dental & vision
Learning Budget
Professional development
Competitive Salary
Market-rate compensation
Remote Work
Work from anywhere flexibility
Generous PTO
Paid time off
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Team information coming soon